Amniotic Membrane Market Amniotic Membrane Market by Product (Cryopreserved Amniotic Membrane and Lyophilization Amniotic Membrane), Application (Surgical Wounds, Ophthalmology and Others), and End User (Hospitals, Ambulatory Surgical Centers, Specialized Clinics, and Research Centers & Laboratory) - Global Opportunity Analysis and Industry Forecast, 2017-2023

February 2018 | 122 pages | ID: A2CFC387781EN
Allied Market Research

Abstracts

The global amniotic membrane market was valued at $812 million in 2016, and is expected to reach $1,563 million by 2023, registering a CAGR of 9.7% during the forecast period. Amniotic membrane is the innermost layer of the placenta, which consists of a thick basement membrane and an avascular stromal matrix. It can be used as a graft and as a dressing to ease ocular surface reconstruction and promote healing for various ailments.

The major factors that drive the growth of the amniotic membrane market is the rise geriatric population coupled with the increase in amniotic membrane based transplantation globally. However, dearth of skilled professionals and high cost of the surgeries involving amniotic membrane restrain the growth of the global amniotic membrane market. Moreover, the increase in awareness regarding the potential benefits of amniotic membrane among the patients as well as the healthcare professionals offers lucrative opportunities that boost the market.
The global amniotic membrane market is segmented based on product, application, end user, and region. Based on product, the market is bifurcated into cryopreserved amniotic membrane and lyophilization amniotic membrane. Based on application, it is divided into surgical wounds, ophthalmology, and others. Based on end user, itis classified into hospitals, ambulatory surgical centers, specialized clinics, and research centers & laboratory. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

• The study provides an in-depth analysis of the global amniotic membrane market, with current trends and future estimations to elucidate the imminent investment pockets.
• Comprehensive analysis of factors that drive and restrict the market growth is provided.
• Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of the key segments of the industry helps understand the type of amniotic membrane used globally.
• Key market players and their strategies are provided to understand the competitive outlook of the market.

KEY MARKET SEGMENTS

By Product

• Cryopreserved Amniotic Membrane
• Lyophilization Amniotic Membrane

By Application

• Surgical Wounds
• Ophthalmology
• Others

By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialized Clinics
• Research Centers & Laboratory

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• Asia-Pacific
• LAMEA

KEY PLAYERS PROFILED

• FzioMed, Inc.
• Skye Biologics Inc.
• IOP Ophthalmics
• Amniox Medical, Inc.
• Amnio Technology, LLC
• Applied Biologics LLC
• Alliqua BioMedical, Inc
• Human Regenerative Technologies, LLC
• Derma Sciences Inc
• MiMedx Group, Inc

Contents

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
  1.4.1. Secondary research
  1.4.2. Primary research
  1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market Definition And Scope
3.2. Key Findings
  3.2.1. Top investment pockets
  3.2.2. Top winning strategies
  3.2.3. Top Winning Strategies, By Year, 2014-2017
  3.2.4. Top Winning Strategies, By Development, 2014-2017 (%)
  3.2.5. Top Winning Strategies, By Company, 2014-2017
3.3. Porters Five Forces Analysis
3.4. Top Player Positioning
3.5. Market Dynamics
  3.5.1. Drivers
    3.5.1.1. Growth in geriatric population
    3.5.1.2. Increasing technological advancements and rising amniotic membrane transplantations
    3.5.1.3. Increased awareness to reduce healthcare costs
  3.5.2. Restraints
    3.5.2.1. Dearth of skilled professionals
  3.5.3. Opportunities
    3.5.3.1. Increasing awareness about the advantages of amniotic membrane transplant

CHAPTER 4: AMNIOTIC MEMBRANE MARKET BY PRODUCT

4.1. Overview
4.2. Market Size and Forecast
4.3. Cryopreserved Amniotic Membrane
  4.3.1. Key market trends, growth factors and opportunities
  4.3.2. Market size and forecast by region
4.4. Lyophilization Amniotic Membrane
  4.4.1. Key market trends, growth factors and opportunities
  4.4.2. Market size and forecast by region

CHAPTER 5: AMNIOTIC MEMBRANE MARKET BY APPLICATION

5.1. Overview
  5.1.1. Market size and forecast
5.2. Surgical Wounds
  5.2.1. Market size and forecast by region
5.3. Ophthalmology
  5.3.1. Market size and forecast by region
5.4. Others
  5.4.1. Market size and forecast by region

CHAPTER 6: AMNIOTIC MEMBRANE MARKET BY END-USER

6.1. Overview
  6.1.1. Market size and forecast
6.2. Hospitals
  6.2.1. Market size and forecast by region
6.3. Ambulatory Surgical Centers
  6.3.1. Market size and forecast by region
6.4. Specialized Clinics
  6.4.1. Market size and forecast by region
6.5. Research Centers & Laboratory
  6.5.1. Market size and forecast by region

CHAPTER 7: AMNIOTIC MEMBRANE MARKET, BY REGION

7.1. Overview
  7.1.1. Market size and forecast
7.2. North America
  7.2.1. North America Market size and forecast by country
  7.2.2. North America Market size and forecast by Product
  7.2.3. North America Market size and forecast by Application
  7.2.4. North America Market size and forecast by End User
    7.2.1.1. U.S. Market size and forecast by product
    7.2.1.2. U.S. Market size and forecast by application
    7.2.1.3. U.S. Market size and forecast by end user
    7.2.1.4. Canada Market size and forecast by product
    7.2.1.5. Canada Market size and forecast by application
    7.2.1.6. Canada Market size and forecast by end user
    7.2.1.7. Mexico Market size and forecast by product
    7.2.1.8. Mexico Market size and forecast by application
    7.2.1.9. Mexico Market size and forecast by end user
7.3. Europe
  7.3.1. Europe Market size and forecast by product
  7.3.1. Europe Market size and forecast by application
  7.3.1. Europe Market size and forecast by end user
7.4. Asia-Pacific
  7.4.1. Asia-Pacific market size and forecast, by product
  7.4.2. Asia-Pacific market size and forecast, by application
  7.4.3. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
  7.5.1. LAMEA Market size and forecast by product
  7.5.1. LAMEA Market size and forecast by application
  7.5.1. LAMEA Market size and forecast by end user

CHAPTER 8: COMPANY PROFILES

8.1. Alliqua BioMedical Inc.
  8.1.1. Company overview
  8.1.2. Company snapshot
  8.1.3. Business performance
  8.1.4. Key strategic moves and developments
8.2. Amnio Technology, LLC
  8.2.1. Company overview
  8.2.2. Company snapshot
  8.2.3. Key strategic moves and developments
8.3. Applied Biologics LLC
  8.3.1. Company overview
  8.3.2. Company snapshot
8.4. FzioMed Inc.
  8.4.1. Company overview
  8.4.2. Company snapshot
8.5. Human Regenerative Technologies, LLC
  8.5.1. Company overview
  8.5.2. Company snapshot
8.6. Integra Lifesciences Holdings Corporation (Derma Sciences Inc.)
  8.6.1. Company overview
  8.6.2. Company snapshot
  8.6.3. Operating business segments
  8.6.4. Business performance
  8.6.5. Key strategic moves and developments
8.7. Katena Products, Inc. (IOP Ophthalmics)
  8.7.1. Company overview
  8.7.2. Company snapshot
8.8. MiMedx Group Inc.
  8.8.1. Company overview
  8.8.2. Company snapshot
  8.8.3. Operating business segments
  8.8.4. Business performance
8.9. Skye Biologics Inc.
  8.9.1. Company overview
  8.9.2. Company snapshot
  8.9.3. Key strategic moves and developments
8.10. Tissue-Tech Inc. (Amniox Medical Inc.)
  8.10.1. Company overview
  8.10.2. Company snapshot
  8.10.3. Key strategic moves and developments

List Of Tables

LIST OF TABLES

TABLE 01. GLOBAL AMNIOTIC MEMBRANE MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 02. GLOBAL CRYOPRESERVED AMNIOTIC MEMBRANE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 03. GLOBAL LYOPHILIZATION AMNIOTIC MEMBRANE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 04. GLOBAL AMNIOTIC MEMBRANE MAREKT, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 05. GLOBAL AMNIOTIC MEMBRANE MARKET FOR SURGICAL WOUNDS, BY REGION, 2016-2023 ($MILLION)
TABLE 06. GLOBAL AMNIOTIC MEMBRANE MARKET FOR OPHTHALMOLOGY, BY REGION, 2016-2023 ($MILLION)
TABLE 07. GLOBAL AMNIOTIC MEMBRANE MARKET FOR OTHERS, BY REGION, 2016-2023 ($MILLION)
TABLE 08. GLOBAL AMNIOTIC MEMBRANE MAREKT, BY END USER, 2016-2023 ($MILLION)
TABLE 09. AMNIOTIC MEMBRANE MARKET FOR HOSPITALS, BY REGION, 2016-2023 ($MILLION)
TABLE 10. AMNIOTIC MEMBRANE MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2016-2023 ($MILLION)
TABLE 11. AMNIOTIC MEMBRANE MARKET FOR SPECIALIZED CLINICS, BY REGION, 2016-2023 ($MILLION)
TABLE 12. AMNIOTIC MEMBRANE MARKET FOR RESEARCH CENTERS & LABORATORY, BY REGION, 2016-2023 ($MILLION)
TABLE 13. AMNIOTIC MEMBRANE MARKET, BY REGION, 2012-2023 ($MILLION)
TABLE 14. NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 15. NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 16. NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 17. NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 18. U.S. AMNIOTIC MEMBRANE MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 19. U.S. AMNIOTIC MEMBRANE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 20. U.S. AMNIOTIC MEMBRANE MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 21. CANADA AMNIOTIC MEMBRANE MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 22. CANADA AMNIOTIC MEMBRANE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 23. CANADA AMNIOTIC MEMBRANE MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 24. MEXICO AMNIOTIC MEMBRANE MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 25. MEXICO AMNIOTIC MEMBRANE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 26. MEXICO AMNIOTIC MEMBRANE MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 27. EUROPE AMNIOTIC MEMBRANE MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 28. EUROPE AMNIOTIC MEMBRANE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 29. EUROPE AMNIOTIC MEMBRANE MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 30. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 31. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 32. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 33. LAMEA AMNIOTIC MEMBRANE MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 34. LAMEA AMNIOTIC MEMBRANE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 35. LAMEA AMNIOTIC MEMBRANE MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 36. ALLIQUA: COMPANY SNAPSHOT
TABLE 37. AMNIO TECHNOLOGY: COMPANY SNAPSHOT
TABLE 38. APPLIED BIOLOGICS: COMPANY SNAPSHOT
TABLE 39. FZIOMED: COMPANY SNAPSHOT
TABLE 40. HRT: COMPANY SNAPSHOT
TABLE 41. INTEGRA: COMPANY SNAPSHOT
TABLE 42. INTEGRA: OPERATING SEGMENTS
TABLE 43. KATENA: COMPANY SNAPSHOT
TABLE 44. MIMEDX: COMPANY SNAPSHOT
TABLE 45. INTEGRA: OPERATING SEGMENTS
TABLE 46. SKYE: COMPANY SNAPSHOT
TABLE 47. TISSUETECH: COMPANY SNAPSHOT

List Of Figures

LIST OF FIGURES

FIGURE 01. GLOBAL AMNIOTIC MEMBRANE MARKET, 2016-2023
FIGURE 02. AMNIOTIC MEMBRANE MARKET SEGMENTATION
FIGURE 03. TOP INVESTMENT POCKETS IN THE GLOBAL AMNIOTIC MEMBRANE MARKET
FIGURE 04. MODERATE BARGAINING POWER OF BUYERS
FIGURE 05. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 06. HIGH THREAT OF NEW ENTRANTS
FIGURE 07. LOW THREAT OF SUBSTITUTION
FIGURE 08. MODERATE COMPETITIVE RIVALRY
FIGURE 09. GLOBAL AMNIOTIC MEMBRANE MARKET: TOP PLAYER POSITIONING
FIGURE 10. RESTRAINTS, DRIVERS & OPPORTUNITIES: GLOBAL AMNIOTIC MEMBRANE MARKET
FIGURE 11. AMNIOTIC MEMBRANE MARKET SEGMENTATION: BY PRODUCT
FIGURE 12. AMNIOTIC MEMBRANE MARKET SEGMENTATION: BY APPLICATION
FIGURE 13. AMNIOTIC MEMBRANE MARKET SEGMENTATION: BY END USER
FIGURE 14. GLOBAL AMNIOTIC MEMBRANE MARKET SEGMENTATION: BY REGION
FIGURE 15. ALLIQUA: NET SALES, 2014-2016 ($MILLION)
FIGURE 16. INTEGRA: NET SALES, 2014-2016 ($MILLION)
FIGURE 17. INTEGRA: REVENUE SHARE BY PRODUCT CATEGORIES, 2016 (%)
FIGURE 18. INTEGRA: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 19. MIMEDX: NET SALES, 2014-2016 ($MILLION)
FIGURE 20. MIMEDX: REVENUE SHARE BY PRODUCT, 2016 (%)